13F
中

SRTS SENSUS HEALTHCARE INC

2026Q1 · CUSIP 81728J109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
41
Δ holders QoQ
-3
Breadth percentile
Top 73%
Whale holders
18
Δ whales
+2
Inst. holding value
$16M
New positions
7
Closed positions
10
Price momentum (1Q)
—
Put / Call
0/3

Breadth history (34 quarters)

2018Q1: Δ+1 · h=12 2018Q2: Δ+0 · h=12 2018Q3: Δ+15 · h=27 2018Q4: Δ-13 · h=14 2019Q1: Δ+9 · h=23 2019Q2: Δ-6 · h=17 2019Q3: Δ+1 · h=18 2019Q4: Δ+5 · h=23 2020Q1: Δ-2 · h=21 2020Q2: Δ+1 · h=22 2020Q3: Δ+1 · h=23 2020Q4: Δ-4 · h=19 2021Q1: Δ+5 · h=24 2021Q2: Δ-2 · h=22 2021Q3: Δ-1 · h=21 2021Q4: Δ+20 · h=41 2022Q1: Δ+14 · h=55 2022Q2: Δ+3 · h=58 2022Q3: Δ+23 · h=81 2022Q4: Δ-13 · h=68 2023Q1: Δ+0 · h=68 2023Q2: Δ-18 · h=50 2023Q3: Δ-9 · h=41 2023Q4: Δ+1 · h=42 2024Q1: Δ+4 · h=46 2024Q2: Δ+2 · h=48 2024Q3: Δ+3 · h=51 2024Q4: Δ+15 · h=66 2025Q1: Δ-12 · h=54 2025Q2: Δ-6 · h=48 2025Q3: Δ-6 · h=42 2025Q4: Δ+2 · h=44 2026Q1: Δ-3 · h=41 2018Q1: holders=12 2018Q2: holders=12 2018Q3: holders=27 2018Q4: holders=14 2019Q1: holders=23 2019Q2: holders=17 2019Q3: holders=18 2019Q4: holders=23 2020Q1: holders=21 2020Q2: holders=22 2020Q3: holders=23 2020Q4: holders=19 2021Q1: holders=24 2021Q2: holders=22 2021Q3: holders=21 2021Q4: holders=41 2022Q1: holders=55 2022Q2: holders=58 2022Q3: holders=81 2022Q4: holders=68 2023Q1: holders=68 2023Q2: holders=50 2023Q3: holders=41 2023Q4: holders=42 2024Q1: holders=46 2024Q2: holders=48 2024Q3: holders=51 2024Q4: holders=66 2025Q1: holders=54 2025Q2: holders=48 2025Q3: holders=42 2025Q4: holders=44 2026Q1: holders=41 -23 -11.5 +0 +11.5 +23 104886 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2022Q3 Top 4% — —
2022Q1 Top 14% — —

Options Sentiment

Put holders
0
QoQ: -1
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.47
EPS YoY
-527.3%
Revenue (TTM)
$0.0B
Revenue YoY
-42.9%
Quarterly Revenue & EPS (4Y)
2022-06-30: $12M 2022-09-30: $9M 2022-12-31: $13M 2023-03-31: $3M 2023-06-30: $5M 2023-09-30: $4M 2023-12-31: $13M 2024-03-31: $11M 2024-06-30: $9M 2024-09-30: $9M 2024-12-31: $13M 2025-03-31: $8M 2025-06-30: $7M 2025-09-30: $7M 2025-12-31: $5M 2026-03-31: $3M 2022-06-30: EPS 0.21 2022-09-30: EPS 0.11 2022-12-31: EPS 0.17 2023-03-31: EPS -0.12 2023-06-30: EPS -0.02 2023-09-30: EPS -0.09 2023-12-31: EPS 0.26 2024-03-31: EPS 0.14 2024-06-30: EPS 0.10 2024-09-30: EPS 0.07 2024-12-31: EPS 0.10 2025-03-31: EPS -0.16 2025-06-30: EPS -0.06 2025-09-30: EPS -0.06 2025-12-31: EPS -0.19 2026-03-31: EPS -0.16 0M 7M 13M $M -0.21 0.04 0.29 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 20 2023-03-31: PE 8.22023-06-30: PE 22.62023-12-31: PE 1572024-03-31: PE 20.42024-06-30: PE 15.82024-09-30: PE 13.42024-12-31: PE 13.42025-03-31: PE 40.5 7 86 165 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)